---
title: "American Express, Live Nation And A Health Care Stock: CNBC's 'Final Trades'"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289591645.md"
description: "CNBC's 'Final Trades' highlights American Express, Eli Lilly, and Live Nation. American Express reported strong Q1 2026 earnings with revenue beating estimates. Eli Lilly received FDA approval for its atopic dermatitis drug EBGLYSS. Live Nation is nearing a 52-week high after Morgan Stanley raised its price target to $200. All three stocks saw gains on Thursday."
datetime: "2026-06-12T11:26:45.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289591645.md)
  - [en](https://longbridge.com/en/news/289591645.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289591645.md)
---

# American Express, Live Nation And A Health Care Stock: CNBC's 'Final Trades'

On CNBC's “Halftime Report Final Trades,” **Jenny Van Leeuwen Harrington**, CEO of Gilman Hill Asset Management, LLC, picked **American Express Company** (NYSE:AXP).

On the earnings front, American Express reported upbeat first-quarter 2026 results on April 23. The company reported quarterly revenue (net of interest expense) growth of 10% year-over-year to $18.91 billion, topping the analyst consensus estimate of $18.62 billion.

Higher Card Member spending drove the increase, along with higher net interest income, growth in card balances and strong card fee growth.

_Don't forget to check out our premarket coverage here_

**Rob Sechan**, CEO of NewEdge Wealth, named **Eli Lilly and Company** (NYSE:LLY) as his final trade.

According to recent news, Eli Lilly announced on June 9 that the U.S. Food and Drug Administration has approved the company's EBGLYSS (lebrikizumab-lbkz) for one maintenance dose every eight weeks in patients with moderate-to-severe atopic dermatitis.

**Joshua Brown**, co-founder and CEO of Ritholtz Wealth Management, said **Live Nation Entertainment, Inc.** (NYSE:LYV) is on the verge of a new 52-week high.

Morgan Stanley analyst Cameron Mansson-Perrone, on Wednesday, maintained Live Nation Entertainment with an Overweight rating and raised the price target from $185 to $200.

## **Price Action**

-   Eli Lilly shares gained 2.2% to close at $1,160.95 on Thursday.
-   American Express shares rose 1.6% to settle at $318.49 during the session.
-   Live Nation shares climbed 2.9% to close at $172.33 on Thursday.

_Photo via Shutterstock_

### Related Stocks

- [AXP.US](https://longbridge.com/en/quote/AXP.US.md)
- [LLY.US](https://longbridge.com/en/quote/LLY.US.md)
- [LYV.US](https://longbridge.com/en/quote/LYV.US.md)
- [LLYX.US](https://longbridge.com/en/quote/LLYX.US.md)
- [LLYZ.US](https://longbridge.com/en/quote/LLYZ.US.md)
- [ELIS.US](https://longbridge.com/en/quote/ELIS.US.md)
- [ELIL.US](https://longbridge.com/en/quote/ELIL.US.md)
- [MS.US](https://longbridge.com/en/quote/MS.US.md)
- [MS-O.US](https://longbridge.com/en/quote/MS-O.US.md)
- [MS-Q.US](https://longbridge.com/en/quote/MS-Q.US.md)
- [MS-E.US](https://longbridge.com/en/quote/MS-E.US.md)
- [MS-I.US](https://longbridge.com/en/quote/MS-I.US.md)
- [MS-L.US](https://longbridge.com/en/quote/MS-L.US.md)
- [MS-P.US](https://longbridge.com/en/quote/MS-P.US.md)
- [MS-A.US](https://longbridge.com/en/quote/MS-A.US.md)
- [MS-F.US](https://longbridge.com/en/quote/MS-F.US.md)
- [MS-K.US](https://longbridge.com/en/quote/MS-K.US.md)

## Related News & Research

- [Clearbridge Investments LLC Has $405.93 Million Stock Holdings in Eli Lilly and Company $LLY](https://longbridge.com/en/news/288953622.md)
- [Key facts: Eli Lilly GLP‑1 wins; AI‑healthcare leader, FCF $47B 2030](https://longbridge.com/en/news/288951082.md)
- [Clal Insurance Enterprises Holdings Ltd Sells 39,034 Shares of Eli Lilly and Company $LLY](https://longbridge.com/en/news/289659135.md)
- [Lilly shares jump as analysts see retatrutide data extending obesity market edge](https://longbridge.com/en/news/289044514.md)
- [AlzeCure signs collaboration, out-licensing deal with Lilly for Alzheimer's drug](https://longbridge.com/en/news/289141264.md)